社区幽门螺杆菌感染根除的障碍
本文讨论在美国高危、医疗服务不足人群中开展社区幽门螺杆菌检测与根除以预防胃癌的障碍。幽门螺杆菌被世界卫生组织列为1类致癌物,在少数族裔和移民中患病率更高,但美国目前未开展幽门螺杆菌筛查。作者评估了社区幽门螺杆菌检测的结果。
要点
- 幽门螺杆菌是美国高危少数族裔和移民人群中胃癌的重要病因。
- 幽门螺杆菌根除符合Wilson和Jungner筛查标准,可降低胃癌风险与死亡。
- 在高胃癌负担国家,幽门螺杆菌根除被视为胃癌的一级预防。
核心结论
- 在美国高危、医疗服务不足人群中开展社区幽门螺杆菌检测可能降低胃癌负担。
研究设计与样本
- 原文未报告研究设计。
主要发现
- 幽门螺杆菌在美国非裔、亚裔、拉丁裔和移民中患病率更高,这些人群也更易患胃癌并死于胃癌。
关键数值与推荐
- 幽门螺杆菌被世界卫生组织列为1类致癌物。
- 幽门螺杆菌根除符合Wilson和Jungner筛查标准。
- 文献持续证明幽门螺杆菌根除可降低胃癌风险与胃癌死亡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Helicobacter pylori (HP) is a causative agent in gastric cancer (GC).1 In the United States, HP is more prevalent in racial and ethnic minorities, including African Americans, Asian Americans, Latinos, and immigrants, the same groups that are more likely to develop and die from GC.2 Although screening for HP is not presently performed in the United States, there are plausible benefits to doing so, because HP is considered a group 1 carcinogen by the World Health Organization, and its link to GC parallels that of human papilloma virus and cervical cancer.1 HP eradication as a means of preventing GC also fulfils the Wilson and Jungner criteria for a successful screening program, and literature has consistently demonstrated that HP eradication reduces GC risk and death from GC.3 In fact, in countries with a high burden of GC, HP eradication is considered primary prevention for GC. As such, targeted HP testing in the United States may reduce GC burden in high-risk groups.4 We evaluate the results of community-based HP testing in an at-risk, underserved population.
引用
- Kumar S, Araque M, Stark VS, et al. Barriers to Community-Based Eradication of Helicobacter pylori Infection. Clin Gastroenterol Hepatol. 2024. PMID: 38580161. doi:10.1016/j.cgh.2024.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。